top of page
Neurotech Landscape Overview 2020 Q4 - A

PLEASE FILL IN THE FORM BELOW TO ACCESS

THE FULL REPORT

“Global NeuroTech Industry Landscape Overview Q4 2020”

“Global NeuroTech Industry Landscape Overview Q4 2020” presents an updated overview of the global NeuroTech landscape, featuring dynamic industry mindmaps that profile 450 Companies, 650 Investors, 260 Influencers, 100 Conferences and 40 Journalists active in the NeuroTech space, interactive charts and graphs, and an 80-page analytical report summarizing key take-aways and trends to watch out for in 2021.

​

The report offers detailed analysis and insights on a number of industry aspects that are critical for effective strategic decision making, including:

​

  • Leading NeuroTech companies, investors, NGOs, hubs, conferences, influencers, journalists, research institutions;

  • Market structure, technology usage and implementation;

  • Current and future trends in the NeuroTech industry, and forecasts of the subsectors, markets, regions and technologies with the strongest prospects for growth and diversification within the next several years;

  • Analysis of the most successful and impactful industry players on the market, and the current shape of the global NeuroTech race;

  • Investment opportunities, problems, and risks;

  • Social and ethical implications of NeuroTech;

  • Short- and long-term market predictions;

  • Structural and geographical allocations.

The Global Neurotech Industry is one of the most promising and prospective sectors of modern BioTech in particular and exponential markets in general. Annual growth of investment in neurotechnology is 31% while the average growth for life science investment, in general, is 12%. Private capital funds invested more than $19 billion in NeuroTech companies since the year 2000. Corporations, investors and other counterparties who succeed in tapping into the current wave of industry growth and development will gain essential competitive advantages in their struggle for new markets, audiences, funding and technologies. 

 

Some NeuroTech subsectors are already well-established and mature, with practical implementations and products either already on the market or set to appear in the next several years, whereas other subsectors are still emerging, and dominated by early-stage startups. Identifying those sectors with the greatest prospects for short-term growth is one of the most important goals for every player in the industry.

bottom of page